SCHEMBL4873274

SCHEMBL4873274

COc1ccc(C(=O)CN2CCNCC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.71
LMNA P02545 2/20 0.69
KDM4E B2RXH2 1/20 0.69
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
PKM P14618 1/20 0.54
TP53 P04637 1/20 0.53
POLB P06746 2/20 0.52
MAPT P10636 1/20 0.52
HTT P42858 1/20 0.52
GSK3B P49841 1/20 0.50
KDR P35968 1/20 0.50
HRH2 P25021 1/20 0.50
HRH1 P35367 1/20 0.50
NSD2 O96028 1/20 0.50
GAA P10253 1/20 0.50
GFER P55789 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3844533 0.98 ALDH1A1 (0.69) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL15935698 0.86 ALDH1A1 (0.94) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL15503835 0.84 ALDH1A1 (0.97) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL16914848 0.84 ALDH1A1 (0.56) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL4874455 0.83 ALDH1A1 (0.76) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL6022700 0.83 MEN1 (0.60) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL2616165 0.83 MEN1 (0.69) ALDH1A1LMNAKDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL1495931 0.81 MEN1 (0.67) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL5168948 0.81 ALDH1A1 (0.49) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL11106554 0.81 ALDH1A1 (0.62) ALDH1A1LMNAKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7326710-B2 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2008-02-05 US claimed
US-20050153981-A1 Aralkyl formly-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2005-07-14 US claimed
EP-1553092-A1 ARALKYL FORMYL-ALKYL PIPERAZINE DERIVATIVES AND THEIR USES AS CEREBRAL NERVE PROTECTIVE AGENT Shanghai Institute of Pharmaceutical Industry (CN) 2005-07-13 EP claimed
US-7326710-B2 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2008-02-05 US disclosed
US-20050153981-A1 Aralkyl formly-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2005-07-14 US disclosed
EP-1553092-A1 ARALKYL FORMYL-ALKYL PIPERAZINE DERIVATIVES AND THEIR USES AS CEREBRAL NERVE PROTECTIVE AGENT Shanghai Institute of Pharmaceutical Industry (CN) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153981-A1 Aralkyl formly-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent GAP43, FABP7, AGK ALDH1A1 1828/4885LMNA 1002/4885KDM4E 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.